Broadening the field of opportunity for medicinal chemists. Official journal of the European Federation for Medicinal Chemistry
Impact Factor 2.722 12 Issues per Year
Concise Article

Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Biotica Technology Ltd., Chesterford Research Park, Cambridge, UK
E-mail: matt.gregory@biotica.com;
Fax: +01799 532921 ;
Tel: +44 1799 532920
b
Department of Immunology and Microbial Science, Scripps Research Institute, La Jolla, USA
c
Rega Institute for Medical Research, K. U. Leuven, 3000 Leuven, Belgium
d
Shanghai Chempartner Co., Zhangjiang Hi-tech Park, Pudong, Shanghai, China
Med. Chem. Commun., 2012,3, 944-949

DOI: 10.1039/C1MD00227A
Received 06 Sep 2011, Accepted 02 Oct 2011
First published online 21 Oct 2011

This article is part of themed collection: Natural Products
| | | | | | More
Please wait while Download options loads
Download Citation
 
 

Supplementary Info